Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 19;108(3):584-587.
doi: 10.4269/ajtmh.22-0503. Print 2023 Mar 1.

Clinico-Epidemiologic Characteristics of Patients Reported in the Mycotic Infections in COVID-19 Registry

Rohan Maini  1 , Neha Saini  1 , Kranti Bhavana  2 , Bhartendu Bharti  2 , Shweta Walia  3 , Neetu Kori  3 , Sushila Kataria  4 , Pooja Sharma  4 , Vikas Deswal  4 , Kavya Atluri  5 , Yatin Sethi  6 , Charuta Mandke  7 , Mayank Chansoria  8 , Sumit Rawat  9 , Rajani Bhat  10 , Ameet Dravid  11 , Chandan Baranwal  12 , Nirmal Sarkar  13 , Sunit Jariwala  1 , Yoram Puius  1 , Shitij Arora  1 ; MUNCO Registry
Affiliations

Clinico-Epidemiologic Characteristics of Patients Reported in the Mycotic Infections in COVID-19 Registry

Rohan Maini et al. Am J Trop Med Hyg. .

Abstract

We update results from the Mycotic Infections in COVID-19 (MUNCO) Registry, May-September 2021. Data collection from May to September 2021 yielded 728 cases from India, Nepal, Bangladesh, Thailand, and the United States. The cases consisted of mostly mucormycosis (97.6%), primarily rhinocerebral, and were analyzed to investigate clinical characteristics associated with negative outcomes. Patients were mostly diabetic (85%) and male (76%), with significant mortality (11.7%). All patients received treatment of coronavirus disease 2019 (COVID-19) as well as antifungal treatment. The crude mortality rate was 11.3% for mucormycosis and 22.7% formixed infections. This study demonstrates the utility of online databases in the collection of high-caliber data.

PubMed Disclaimer

References

    1. Baddley JW. et al., 2021. Coronavirus disease 2019–associated invasive fungal infection. Open Forum Infect Dis. 8: ofab510. - PMC - PubMed
    1. Arora S. et al., 2021. Online registry of COVID-19–associated mucormycosis cases, India, 2021. Emerg Infect Dis 27: 2963–2965. - PMC - PubMed
    1. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG, 2009. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42: 377–381. - PMC - PubMed
    1. Singh AK, Singh R, Joshi SR, Misra A, 2021. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 15: 102146. - PMC - PubMed
    1. Kuehn BM, 2020. Pulmonary fungal infections affect patients with COVID-19. JAMA 324: 2248. - PubMed

Publication types

Substances